Definium Therapeutics Inc.
DFTX | NASDAQ
$33.64
-$2.69 (-7.40%)
Nov 2, 2026, 12:10 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -158.99M | -77.1M | -50.44M | -67.27M | -42.74M | -23.35M | -34.74M | -13.68M | -5.85M | -54.4M | -23.86M | -17.92M | -29.13M | -24.82M | -4.9M | -16.49M | -16.96M | -18.45M | -18.75M | -17.2M | -45.25M | -13.76M |
Depreciation & Amortization | -631K | 631K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 527K | 790K | 791K | 790K | 791K | 790K | 790K | 820K | 780K | -5.09M | 789K | 779K | 260K |
Stock-Based Compensation | 9.64M | 7.13M | 11.42M | 5.82M | 5.25M | 3.43M | 3.45M | 3.77M | 5.43M | 3.69M | 3.68M | 4.23M | 3.84M | 3.75M | 1.38M | 4.29M | 4.25M | 3.79M | 11.04M | 4.11M | 32.99M | 1.28M |
Other Working Capital | 6.45M | 3.67M | -1.63M | 4.2M | 6.14M | -2.72M | -86K | 4.63M | -488K | -2.19M | -286K | -207K | 3.21M | 1.54M | -3.41M | 499K | -674K | 1.86M | -2.46M | -5.17M | 1.95M | 601K |
Other Non-Cash Items | 90.92M | 21.26M | 1.61M | 23.79M | -197K | -7.04M | 6.17M | -11.37M | -16.12M | 34.26M | 2.63M | -2.58M | 14K | 5.2M | -7.98M | 1.51M | 17K | n/a | 1.23M | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.17M | n/a | n/a | n/a | n/a | n/a | -1.16M | n/a | n/a | n/a |
Change in Working Capital | 6.28M | 5.45M | -4.48M | 8.1M | 8.09M | -2.46M | -225K | 4.1M | -3.45M | -677K | -3.8M | -1.14M | 9.47M | 1.74M | -2.13M | 599K | -3.26M | 1.01M | -1.18M | -4.48M | 314K | 2.18M |
Operating Cash Flow | -52.78M | -42.63M | -41.89M | -29.57M | -29.6M | -29.42M | -25.35M | -17.19M | -19.99M | -16.6M | -20.56M | -16.63M | -13.85M | -13.33M | -12.85M | -9.3M | -15.13M | -12.87M | -13.9M | -16.78M | -11.17M | -10.04M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | n/a | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 178K | n/a | n/a | -297K |
Purchase of Investments | -355.74M | n/a | -2.55M | -26.59M | -73.29M | -162.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 39M | 42M | 40.08M | 42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 33.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -27K | -67K | -17K |
Investing Cash Flow | -316.74M | 42M | 37.53M | 15.41M | -39.54M | -162.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | -27K | -67K | -316K |
Debt Repayment | n/a | n/a | -259.19K | 447K | 19.91M | n/a | 984K | n/a | 9.8M | -128K | -42K | 14.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -407K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -46.36M | n/a | 515.88K | -455.06K | -377.01K | 816K | 3.81M | -5.65M | 1.4M | -6.61M | 49K | 114K | n/a | n/a | -314K | 16.64M | 590K | 241K | 128K | 824K | 8.07M | 1K |
Financial Cash Flow | 762.27M | 5.31M | 246.62M | 749K | 19.65M | 1M | 3.81M | 69.35M | 10.79M | 169.25M | 2.59M | 17.4M | 1.27M | 583K | 416K | 58.21M | 590K | -166K | 129K | 820K | 7.89M | 89.99M |
Net Cash Flow | 392.75M | 4.68M | 237.88M | -13.43M | -49.46M | -190.89M | -21.54M | 52.15M | -9.2M | 152.63M | -18M | 804K | -12.51M | -12.73M | -12.38M | 48.78M | -14.73M | -13.07M | -12.38M | -11.18M | -2.94M | 79.9M |
Free Cash Flow | -52.78M | -42.63M | -41.89M | -29.57M | -29.6M | -29.42M | -25.35M | -17.19M | -19.99M | -16.6M | -20.56M | -16.63M | -13.85M | -13.33M | -12.85M | -9.3M | -15.13M | -12.87M | -13.85M | -16.78M | -11.17M | -10.04M |
Adj. Free Cash Flow | -62.42M | -49.76M | -53.31M | -35.38M | -34.85M | -32.85M | -28.8M | -20.96M | -25.42M | -20.29M | -24.24M | -20.85M | -17.69M | -17.08M | -14.23M | -13.58M | -19.38M | -16.66M | -24.89M | -20.89M | -44.16M | -11.32M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -47K | n/a | n/a | -2K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94K | n/a | n/a | n/a |
Owner Earnings | -52.78M | -42.63M | -41.89M | -29.57M | -29.6M | -29.42M | -25.35M | -17.19M | -19.99M | -16.6M | -20.56M | -16.63M | -13.85M | -13.33M | -12.85M | -9.3M | -15.13M | -12.87M | -13.95M | -16.78M | -11.17M | -10.04M |
Add to Watchlist
Select watchlists to add or remove DFTX